LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.
Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.
Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.
A pan-European survey is being conducted with the aim to understand the following about people’s experience with non-small cell lung cancer (NSCLC), with the overall aim of better understanding experience during the care pathway, as well as needs and expectations in terms of innovative treatments. More specifically, the survey will explore: perception of the disease burden on the daily life […]
Lung Cancer Europe (LuCE) held a webinar on how drug prices are determined. The webinar was given by Eric Low, owner and founder of Eric Low Consulting Ltd. The webinar was held and recorded on 2nd July 2020.
Lung Cancer Europe (LuCE) is holding a webinar on how drug prices are determined and how their value is assessed in the European countries. The webinar is intended for an audience of advocates, patients and caregivers. It will be given by Eric Low, owner of Eric Low Consulting Ltd and active member of a number of cancer-related boards, steering groups […]
Lung Cancer Europe (LuCE) held a webinar on what clinical trails are and they are conducted. The webinar was given by Saskia Litière, Head of Statistics Department and Anastassia Negrouk, Head of Internacional Policy Department, at the European Organisation for Research and Treatment of Cancer (EORTC) The webinar was held and recorded on 17th June 2020.
